🇺🇸 FDA
Patent

US 7863275

Uses of tetrahydrobiopterin and derivatives thereof

granted A61KA61K31/4985A61P

Quick answer

US patent 7863275 (Uses of tetrahydrobiopterin and derivatives thereof) held by The Board of Regents of the University of Texas System expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/4985, A61P, A61P1/00